BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4 | -33.3% | 177 | -0.6% | 0.00% | -40.0% |
| Q2 2023 | $6 | +20.0% | 178 | -0.6% | 0.01% | +25.0% |
| Q1 2023 | $5 | -64.3% | 179 | -50.0% | 0.00% | -33.3% |
| Q4 2022 | $14 | -99.7% | 358 | +216.8% | 0.01% | +50.0% |
| Q3 2022 | $5,000 | – | 113 | +1783.3% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 6 | -95.2% | 0.00% | -100.0% |
| Q1 2022 | $7,000 | +16.7% | 124 | +67.6% | 0.01% | -37.5% |
| Q4 2021 | $6,000 | – | 74 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |